Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines

Cancer Epidemiology
Nadège RabiauDominique Bernard-Gallon

Abstract

The prostate cancer most frequently affects men. The ethnic origin and family antecedents of prostate cancer are established as risk factors. The genetic factors associated with environmental factors such as the nutrition also play a role in the development of the cancer. Epidemiological studies showed that the Asian populations exhibited an incidence of prostate cancer markedly subordinate by comparison with the Western populations. This would be explained partially by their important consumption of soy. Both main phytoestrogens of soy, the genistein and the daidzein, present anti-proliferative properties. For that purpose, we used different prostate cancer cell lines (LNCaP, DU 145, PC-3) and, by flow cytometry, we determined the concentration of phytoestrogens inducing a cell cycle arrest and the required time of incubation. Then, the effects of 40microM genistein or 110microM daidzein for 48h were determined and studied on the expression of genes involved in the human cell cycle and angiogenesis and conducted by SYBR green quantitative PCR. We demonstrated modulations of cyclin-dependent kinase-related pathway genes, DNA damage-signaling pathway and a down-regulation of EGF and IGF.

References

Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T FotsisL Schweigerer
Jan 1, 1995·Proceedings of the Society for Experimental Biology and Medicine·S Barnes, T G Peterson
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Dec 31, 1997·Molecular and Cellular Biology·L J KoZ Q Pan
Dec 10, 1999·International Journal of Cancer. Journal International Du Cancer·A W HsingS S Devesa
Jul 25, 2000·Biochemical and Biophysical Research Communications·D A FavyD Bernard-Gallon
Nov 7, 2000·Current Opinion in Cell Biology·H TakisawaY Kubota
Jan 16, 2002·Cancer Letters·Takashi KobayashiTakejiro Kuzumaki
Aug 17, 2002·Cancer Letters·Jun WangCoral A Lamartiniere
Mar 13, 2003·Kidney International·Mark BuzzaJudy Savige
Jun 7, 2003·Endocrine-related Cancer·J SimardS V Tavtigian
Jun 11, 2003·Nutrition Reviews·Mark J Messina
Mar 24, 2004·The British Journal of Nutrition·Pamela J Magee, Ian R Rowland
Sep 29, 2004·Journal of Clinical Pathology·V PadmanabhanB G Beatty
Sep 30, 2004·Technology in Cancer Research & Treatment·S LehrerR G Stock
Oct 19, 2004·Nutrition and Cancer·Nader S ShenoudaRuth S Macdonald
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Apr 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Hong Gee Sim, Christopher W S Cheng
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ming Zhu FangChung S Yang
Mar 21, 2007·Journal of Carcinogenesis·Jun WangCoral A Lamartiniere
Nov 23, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marc ColonnaBrigitte Tretarre
Feb 28, 2008·The Cancer Journal·Jeanny B Aragon-Ching, William L Dahut
Jun 25, 2008·The British Journal of Nutrition·Claudia SteinerClaudine Manach

❮ Previous
Next ❯

Citations

Jun 3, 2010·Clinical & Experimental Metastasis·Michelle M Martínez-MontemayorSuranganie Dharmawardhane
Nov 5, 2014·Expert Review of Anticancer Therapy·Venita H Patel
May 27, 2015·International Journal of Molecular Sciences·Lenka VarinskaJan Mojzis
Jan 26, 2012·Annals of Neurology·Jessica de RuijterFrits A Wijburg
Mar 16, 2013·Molecular Nutrition & Food Research·Shailendra Kapoor
Jan 1, 2014·The Journal of Steroid Biochemistry and Molecular Biology·Abeer M MahmoudMaarten C Bosland
Apr 2, 2015·Omics : a Journal of Integrative Biology·Seher Karsli-CeppiogluDominique Bernard-Gallon
Jan 17, 2015·Annales d'endocrinologie·Mawussi AdjaklyDominique Bernard-Gallon
Mar 5, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lenka VarinskaPeter Kruzliak
Dec 23, 2017·International Journal of Molecular Sciences·Ladislav MirossayJán Mojžiš
Jan 27, 2019·Molecular and Clinical Oncology·Monika Kmetová SivoňováJana Jurečeková
Sep 13, 2020·European Journal of Clinical Nutrition·Chisato Nagata
Sep 21, 2017·Medicines·Samira Ziaei, Reginald Halaby
Aug 27, 2019·DNA Repair·Maryam MajidiniaBahman Yousefi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.